Our Vision

to relieve patient suffering and enhance lives

Using our novel R&D platform for the advancement of life-changing medicines, we focus on neurological and endocrine based diseases and disorders.

Learn More

Endometriosis and Uterine Fibroids

Not all patients suffer the same way.

We are investigating a first-in-class, oral treatment option that addresses the chronic, intermittent, predictable and unpredictable symptoms common to Endometriosis and Uterine Fibroids.

Learn More

Tardive Dyskinesia

is a potentially debilitating movement disorder.

We are investigating a novel therapy for the treatment of involuntary movements caused by exposure to dopamine receptor blocking agents.

Learn More

Tourette Syndrome

can mean life interrupted.

We are investigating a once-daily treatment for tics associated with Tourette syndrome.

Learn More

Congenital Adrenal Hyperplasia

requires life long care.

We are investigating a non-steroidal therapy for Classical CAH to treat the effects of life-long elevated androgens and the use of high-dose corticosteroids both of which can lead to the virilization of females, metabolic syndrome, bone loss, growth impairment, and Cushing's syndrome.

Learn More